e-learning
resources
Munich 2006
Sunday 03.09.2006
Epidemiology of drug resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of the aetiological agent in patients with lung tuberculosis
M. V. Chernykh, G. I. Alexeeva (Yakutsk, Russian Federation)
Source:
Annual Congress 2006 - Epidemiology of drug resistant tuberculosis
Session:
Epidemiology of drug resistant tuberculosis
Session type:
E-Posters in free access
Number:
179
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. V. Chernykh, G. I. Alexeeva (Yakutsk, Russian Federation). Characterization of the aetiological agent in patients with lung tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 179
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Characterization of the aetiological agent in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010
Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004
The prevalance of tuberculosis in patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004
Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
Accidental detection of mycobacterium tuberculosis infection in patients with various respiratory diseases
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
A pathogen in patients with underlying lung disease: corynebacterium pseudodiphtericum
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
The coexistance of active pulmonary tuberculosis in lung cancer patients
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Diagnosis of COPD in patients with multidrug-resistant tuberculosis
Source: International Congress 2018 – COPD around the world
Year: 2018
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Diaskintest at patients after successful treatment of lung tuberculosis
Source: International Congress 2017 – Migrants and screening
Year: 2017
Prevalence of pulmonary tuberculosis in spinal tuberculosis patients
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Pharmacokinetics of drugs for non tuberculous mycobacterial lung infections
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept